Literature DB >> 22745048

Metronomic therapy for malignant peripheral nerve sheath tumor in neurofibromatosis type 1.

Narendra Chaudhary1, Anupama Borker.   

Abstract

Malignant peripheral nerve sheath tumor (MPNST) is a highly aggressive tumor especially in the patients with neurofibromatosis type 1 (NF1). Without a complete surgical excision, prognosis is guarded. We describe a 10-year-old male with NF1 with MPNST, who had a local relapse within 5 weeks of surgical excision. Chemoradiotherapy did not result in tumor regression. Initiation of palliative oral metronomic therapy resulted in complete remission after six cycles. The patient continues to be in remission, 20 months after completion of nine cycles of metronomic therapy. Metronomic therapy may be effective in MPNST where conventional chemotherapy and radiotherapy fails.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22745048     DOI: 10.1002/pbc.24245

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  2 in total

1.  Neurofibromatosis: chronological history and current issues.

Authors:  João Roberto Antônio; Eny Maria Goloni-Bertollo; Lívia Arroyo Trídico
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

2.  A rare case of cecal malignant peripheral nerve sheath tumor in a dog.

Authors:  Hyerin Ahn; Woo-Jin Song; Solji Choi; Jae-Hoon Kim; Ji-Youl Jung; Jongtae Cheong; Hyunjung Park; Hyohoon Jeong; Youngmin Yun
Journal:  J Vet Med Sci       Date:  2022-06-21       Impact factor: 1.105

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.